News Releases

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
11/20/2017
8:00 AM ET
Press Release

Diffusion Pharmaceuticals Regains Compliance with Nasdaq Capital Market Minimum Equity Rule

11/20/2017

CHARLOTTESVILLE, Va., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(Nasdaq:DFFN) (“Diffusion” or “the Company”), is a clinical-stage biotechnology company focused on extending the...

 Continue Reading
11/13/2017
8:00 AM ET
Earnings Release

Diffusion Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update

11/13/2017

FDA Clears Phase 3 Protocol for Patient Enrollment in GBM Brain Cancer Trial“First Patient In” Expected this YearCompany Charter Amendment Addresses Nasdaq Listing IssueAdditions to Board and Manageme...

 Continue Reading
10/17/2017
7:30 AM ET
Press Release

Diffusion Pharmaceuticals Receives Final FDA Protocol Guidance for Phase 3 Clinical Trial with TSC in Patients Newly Diagnosed with Inoperable Glioblastoma Multiforme

10/17/2017

CHARLOTTESVILLE, Va., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the li...

 Continue Reading
10/10/2017
10:00 AM ET
Press Release

Diffusion Pharmaceuticals to Present at the 2017 BIO Investor Forum

10/10/2017

CHARLOTTESVILLE, Va., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on the development...

 Continue Reading
9/5/2017
11:11 AM ET
Press Release

Diffusion Pharmaceuticals to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

9/5/2017

CHARLOTTESVILLE, Va., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on the development...

 Continue Reading
8/23/2017
7:30 AM ET
Press Release

Diffusion Pharmaceuticals Names William Hornung Chief Business Officer

8/23/2017

CHARLOTTESVILLE, Va., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on the development...

 Continue Reading
8/14/2017
4:01 PM ET
Earnings Release

Diffusion Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update

8/14/2017

CHARLOTTESVILLE, Va., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on the development...

 Continue Reading
Displaying 1 to 7 (of 85 releases)